Fear of cancer recurrence and quality of life among gynaecological cancer survivors under treatment

2021 ◽  
Vol 31 ◽  
pp. S276-S280
Author(s):  
Ni Kadek Puspitasari Ayu ◽  
Yati Afiyanti
Keyword(s):  
Quality Of Life ◽  
Cancer Survivors ◽  
Cancer Recurrence ◽  
Gynaecological Cancer ◽  
Fear Of Cancer Recurrence ◽  
Fear Of Cancer

scholarly journals Fear of Cancer Recurrence in Stomach Cancer Survivors: Exploring Socio-Demographic, Physical, Psychological and Quality of Life-Related Factors

2021 ◽  
Author(s):  
Jinyoung Shin ◽  
Dong Wook Shin ◽  
Jungkwon Lee ◽  
JiHye Hwang ◽  
Ji Eun Lee ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Stomach Cancer ◽  
Cancer Recurrence ◽  
Physical Symptoms ◽  
Fear Of Cancer Recurrence ◽  
Related Factors ◽  
Prevention Activity ◽  
Fear Of Cancer ◽  
Stomach Cancer Survivors

Abstract Background: This study aimed to evaluate factors related to the fear of cancer recurrence (FCR) in stomach cancer survivors.Methods: A total of 363 stomach cancer survivors were divided into three groups according to the Korean version of the FCR Index (FCRI). We compared the socio-demographic and cancer-related factors, communication within the medical team during treatment, care coordination, social support, physical symptoms, psychological distress, and health-related quality of life (HRQoL), and health promotion and disease prevention activity, which was defined as second primary cancer screening, osteoporosis evaluation, supplementary drug intake, dietary pattern, regular exercise, and smoking cessation, according to the levels of FCRI using the linear regression analysis after adjusting for age, sex, stage, time since diagnosis, family cancer diagnosis, and comorbidities.Results: An average of 7.3 years have passed since diagnosis. The highest FCRI group was younger or had a high percentage of family cancer diagnosis. Satisfaction for communication and care coordination, social support, HRQoL, and physical symptoms, such as fatigue, pain, and insomnia, were negatively associated with the FCR of stomach cancer survivors. Anxiety and depression were positively associated with the FCR. However, FCR was not associated with sex, time since diagnosis, cancer stage, treatment modality, socioeconomic status, or health promotion and disease prevention activity.Conclusions: FCR in stomach cancer survivors was associated with physical, psychological, and HRQoL factors rather than socio-demographic or cancer–related factors. Understanding the association between HRQoL, physical and psychosocial factors, and FCR may advance survivorship care for stomach cancer survivors.

Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett’s esophagus

Endoscopy ◽  
2010 ◽  
Vol 42 (07) ◽  
pp. 525-531 ◽  
Author(s):  
W. Rosmolen ◽  
K. Boer ◽  
R. de Leeuw ◽  
C. Gamel ◽  
M. van Berge Henegouwen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Surgical Treatment ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Fear Of Cancer

scholarly journals Qualitative Findings Following Acceptance and Commitment Therapy for Breast Cancer Survivors with Fear of Cancer Recurrence

2020 ◽  
Vol 3 ◽  
Author(s):  
Christine Shepler ◽  
Elizabeth Cottingham ◽  
Patrick Stutz ◽  
Shelley Johns
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Acceptance And Commitment Therapy ◽  
Breast Cancer Survivors ◽  
Qualitative Interviews ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Acceptance And Commitment ◽  
Fear Of Cancer

Background: Fear of cancer recurrence (FCR) takes an emotional toll on cancer survivors and significantly undermines quality of life following treatment. During a randomized controlled trial of Acceptance and Commitment Therapy (ACT) for post-treatment breast cancer survivors with clinically significant FCR, we conducted qualitative interviews to glean a deeper understanding of the impact of ACT on survivors’ coping with FCR.  Methods: Breast cancer survivors (stage I-III) who had completed a 6-week ACT intervention were invited to share their experiences in semi-structured qualitative interviews. Interviews were transcribed verbatim and analyzed thematically using a deductive approach. Participants received a $25 gift card for their time. Participants (n=16) were primarily White (81.3%) and college educated (68.8%), with a mean age of 57.3 (SD=11.1) and 75% had an income over $50,000.    Results: Prior to the study, survivors generally coped with FCR by denying their FCR or by attempting to control their fears through faith, lifestyle management, avoidance, and positivity. Survivors uniformly noted the sense of community they felt in their ACT group when listening to other survivors describe their own struggle with FCR. This common bond created a foundation that allowed survivors to embrace the ACT intervention and develop adaptive coping skills related to acceptance, present-moment awareness, and living consistently with one’s values. Survivors noted that these skills reduced the negative impact of FCR and other life challenges and improved quality of life compared to pre-study coping techniques.  Conclusion and Potential Impact: By building trust with other cancer survivors, participants were able to shift from attempts to ‘control’ FCR to a more ‘accepting’ approach to manage FCR and other life stressors. While research with a larger group of participants is needed, initial findings indicate that ACT may be a promising addition to care for cancer survivors. 

scholarly journals Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer

2021 ◽  
Author(s):  
Christine Maheu ◽  
Sophie Lebel ◽  
Christine Courbasson ◽  
Monique Lefebvre ◽  
Mina Singh ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cancer Survivors ◽  
Perceived Risk ◽  
Gynecological Cancer ◽  
Cancer Recurrence ◽  
Fear Of Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Control Group ◽  
Risk Of Cancer

Background Clinically significant levels of fear of cancer recurrence (FCR) affect up to 49 % of cancer survivors and are more prevalent among women. FCR is associated with psychological distress, lower quality of life, and increased use of medical resources. Despite its prevalence, FCR is poorly addressed in clinical care. To address this problem, we first developed, and pilot tested a 6-week, 2 h, Cognitive-existential group intervention therapy that targeted FCR in survivors of breast or gynecological cancer. Following the positive outcome of the pilot, we are now testing this approach in a randomized clinical trial (RCT). Goal and hypotheses: This multicenter, prospective RCT aims to test the efficacy of the intervention. The study hypotheses are that, compared to a control group, cancer survivors participating in the intervention (1) will have less FCR, (2) will show more favorable outcomes on the following measures: cancer-specific distress, quality of life, illness uncertainty, intolerance of uncertainty, perceived risk of cancer recurrence, and coping skills. We further postulate that the between-group differences will persist three and 6 months post-intervention. Methods Sixteen groups of seven to nine women are being allocated to the intervention or the control group. The control group receives a 6-week, 2 h, structurally equivalent support group. We are recruiting 144 cancer survivors from four hospital sites in three Canadian cities. The sample size was based on the moderate pre/post-test changes found in our pilot study and adjusted to the drop-out rates. Measurements: The primary outcome, FCR, is measured by the Fear of Cancer Recurrence Inventory. Secondary outcomes measured include cancer-specific distress, perceived risk of cancer recurrence, illness uncertainty, intolerance of uncertainty, coping, and quality of life. We use reliable and recognized valid scales. Participants are to complete the questionnaire package at four times: before the first group session (baseline), immediately after the sixth session, and 3 and 6 months post-intervention. Analysis: In the descriptive analysis, comparison of group equivalent baseline variables, identification of confounding/intermediate variables and univariate analysis are planned. Each participant’s trajectory is calculated using Generalized Estimating Equation models to determine the time and group effects, after considering the correlation structures of the groups. An intent-to-treat analysis approach may be adopted. Discussion Our Fear of Recurrence Therapy (FORT) intervention has direct implications for clinical service development to improve the quality of life for patients with breast (BC) and gynecological cancer (GC). Based on our pilot data, we are confident that the FORT intervention can guide the development of effective psychosocial cancer survivorship interventions to reduce FCR and improve psychological functioning among women with BC or GC.

Fear of cancer recurrence and quality of life among survivors of pancreatic and periampullary neoplasms.

2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 289-289 ◽  
Author(s):  
Maria Q. B. Petzel ◽  
Nathan H Parker ◽  
Alan D. Valentine ◽  
Sebastien Simard ◽  
Graciela M Nogueras Gonzalez ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Pancreatic Neoplasms ◽  
Depression Scale ◽  
Cancer Recurrence ◽  
Psychosocial Distress ◽  
Fear Of Cancer Recurrence ◽  
Periampullary Adenocarcinoma ◽  
Periampullary Neoplasms ◽  
Fear Of Cancer

289 Background: Fear of Cancer Recurrence (FCR) is well documented among survivors of breast, colon and prostate cancer. Incurable recurrence is common following resection of pancreatic and periampullary neoplasms. The incidence and significance of FCR in this population is unknown. We hypothesized that FCR represents an important source of psychosocial distress following resection of pancreatic neoplasms. Methods: We conducted a cross-sectional study of patients with non-recurrent pancreatic ductal (PDAC), periampullary adenocarcinoma or pancreatic neuroendocrine tumor (PNET) treated with potentially curative surgery 1991–2011. We assessed 7 discrete dimensions of FCR using the Fear of Recurrence Inventory (FCRI) and evaluated quality of life (QOL) and psychosocial distress using the Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire and Hospital Anxiety and Depression Scale. Participants completed these validated instruments by mail. Results: 188 (53%) of 355 eligible patients completed at least one instrument, a median of 49 months (range, 6–222 months) following potentially curative resection. Participants included 73 (39%) patients with PDAC, 55 (29%) with periampullary adenocarcinoma, and 60 (32%) with PNET. The median FCR severity score was higher than a previously established cutoff for clinical significance in 55%, 51% and 63% of patients with PDAC, periampullary adenocarcinoma and PNET, respectively. Older age, male gender, periampullary adenocarcinoma, negative lymph nodes, and longer interval since operation were clinical factors associated with lower total FCR score (all p<0.05). In multivariate analysis, only age (p=0.01) and gender (p=0.03) were independently associated with severity of FCR. A higher total FCR score was significantly associated with higher anxiety (r=0.64), depression (r=0.41) and lower QOL (r =−0.53), all p<0.001. Conclusions: Fear of cancer recurrence is pervasive following resection of pancreatic neoplasms, regardless of survivors’ histopathologic diagnosis, disease severity, or time since resection. Given its association with anxiety, depression and lower QOL, FCR represents a critical therapeutic target.

scholarly journals Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection

2019 ◽  
Vol 89 (3) ◽  
pp. 533-544 ◽  
Author(s):  
Hao Dang ◽  
Wouter H. de Vos tot Nederveen Cappel ◽  
Sarita M.S. van der Zwaan ◽  
M. Elske van den Akker-van Marle ◽  
Henderik L. van Westreenen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Cancer Patients ◽  
Tumor Resection ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
T1 Colorectal Cancer ◽  
Fear Of Cancer ◽  
Colorectal Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document